This Week in the Journal

No serious adverse events were reported. see (Original Article, N Engl J Med 2017;376:41-51) Clinical Trials Series: The Large Pharmaceutical Company Perspective The former chief medical officer of a large pharmaceutical company addresses the issue of complexity and how it affects the performance of clinical trials. see (Review Article, N Engl J Med 2017;376:52-60) Arrhythmogenic Right Ventricular Cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy is a heritable heart-muscle disorder that causes progressive replacement of right ventricular myocardium by fibrofatty tissue..

Medienart:

Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:376

Enthalten in:

The New England journal of medicine - 376(2017), 1, Seite 10

Sprache:

Englisch

Links:

search.proquest.com

BKL:

44.60

44.00

Themen:

Cardiomyopathy
Cholesterol
Clinical medicine
Clinical trials
Health care policy
Health risk assessment
Kidneys
Mastectomy

RVK:

RVK Klassifikation

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC198905322X